shouldiuse.io

Categories

VERDICT

Iqvia Review

Depends

Should I use Iqvia?

Skip to main content - iqvia.com

· 1 month ago

IQVIA is the healthcare-data standard for large pharma, medtech, and CROs that need regulated data and can handle enterprise contracts. Startups, non-healthcare teams, and budget-limited mid-market buyers should pick a cheaper healthcare-data rival.

Confidence

Medium. Based on 20+ public sources; most snippets were truncated, which limits verbatim quotes.

Ratings

  • Value for money
  • Ease of useNo user evidence on usability
  • Feature depth
  • Support qualityNo buyer-facing support evidence found
  • Security posture

Pricing

Enterprise contracts

From $500 (third-party estimate)

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed

Best for

  • Large pharma and biotech
  • Medtech commercial teams
  • Clinical-trial sponsors
  • Regulated health-data analytics

Not for

  • Startups and small teams
  • Non-healthcare companies
  • Budget-constrained mid-market pharma
  • Anyone wanting self-serve, transparent pricing

Gotchas - check before you buy

high

GDPR fines total €12M across France and Italy in 2026 — request current compliance evidence before contracting.

high

Italy case involved one million patients' unencrypted data — verify encryption controls in your deal.

medium

Published estimates start at $500, but unit and contract structure are unconfirmed.

Pros and cons

Pros

  • Pharma industry standard for healthcare data and sales intelligence.
  • Broad portfolio: analytics, clinical trials, safety, compliance.
  • 4.3/5 G2 seller rating across 18 product reviews.
  • Dedicated compliance tooling including a pharmacovigilance platform.

Cons

  • Fined €5M by France's CNIL over health-data processing (May 2026).
  • €7M Italian fine over one million patients' unencrypted data.
  • No public pricing; enterprise contracts only.
  • Mid-market pharma buyers find it unaffordable versus rivals.

Sources & method

- 10 sources - Mature security program (named CISO, monitored vendor-risk reports), but two 2026 EU GDPR fines over patient data.

official x1review x7security x1news x1
  • CNIL fine: €5M over health data, France's data regulator fined IQVIA €5M in May 2026 over health-data processing failures.
  • Italian fine: €7M over unencrypted patient data, Italian regulators moved to fine IQVIA €7M after health data of one million patients was left unencrypted.

Key stats

  • Value for money: 2/5

    Rating

  • From $500 (third-party estimate)

    Starting price

  • 10

    Sources

  • Analyzed

  • Value for money: 2/5. Opaque contracts; cheaper mid-market rivals exist
  • Ease of use. No user evidence on usability
  • Feature depth: 5/5. Broadest health-data portfolio; industry standard
  • Support quality. No buyer-facing support evidence found
  • Security posture: 2/5. Two 2026 EU GDPR fines over patient data
  • 4.3/5 G2 seller rating 18 product reviews
  • From $500 Starting price Third-party estimate; unit unconfirmed
  • 3.7/5 Employee rating 5,700+ AmbitionBox reviews
  • 15,524 Glassdoor reviews Employee reviews

Pricing

Enterprise contracts

From $500 (third-party estimate)

  • Negotiated per organization
  • Data, analytics, and consulting bundles
  • Contact-sales only

Security

Mature security program (named CISO, monitored vendor-risk reports), but two 2026 EU GDPR fines over patient data.

  • CNIL fine: €5M over health dataFrance's data regulator fined IQVIA €5M in May 2026 over health-data processing failures.⁵
  • Italian fine: €7M over unencrypted patient dataItalian regulators moved to fine IQVIA €7M after health data of one million patients was left unencrypted.⁶

What users say

Product reviews are positive (4.3/5 G2 seller rating), while employee reviews average 3.7/5 across 5,700+ AmbitionBox ratings.

Companies that use it

Full analysis

Based on 20+ public sources; most snippets were truncated, which limits verbatim quotes.

Pharma's data giant: industry-standard health analytics with enterprise-only pricing. Overkill outside big life sciences.

Methodology

Based on 20+ public sources; most snippets were truncated, which limits verbatim quotes.

Read how a report is made.

Sources

  1. IQVIA Products | Read 18 Reviews on G2g2.com
    review
  2. IQVIA Reviews by 5700+ Employees | Rated 3.7/5ambitionbox.com
    review
  3. IQVIA Reviews (15524): Pros & Cons of Working At IQVIAglassdoor.com
    review
  4. IQVIA Plans & Hidden Fees (2026)itqlick.com
    review
  5. Health data: fine of 5 million euros against IQVIAcnil.fr
    security
  6. IQVIA fined €7m in Italy for GDPR breach over identifiable patient datamlex.com
    news
  7. Best Healthcare Sales Intelligence | The CRO Reportthecroreport.com
    review
  8. IQVIA Alternatives for Mid-Market Pharma: Affordableglnkco.com
    review
  9. IQVIA's Healthcare Data & Analytics Product Portfoliointuitionlabs.ai
    review
  10. Biovac's Drive for Innovationiqvia.com
    official

Add this review to your site

This check for Iqvia says Depends.

Put the badge on your site.

Visitors see the independent review.

The link points here, and search engines follow it.

This is the badge visitors see on your site.

Depends Iqvia Independent review on Should I Use It

Paste one snippet. Keep the link as it is. A nofollow tag stops search engines from following it.

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.